Preexisting cardiovascular abnormalities are an important predictor of adverse health outcomes among women with and without cancer in the WHI.

The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.

Professor Bogda Koczwara AM will drive innovation at UNSW Sydney and Cancer Council NSW’s Australian Research Centre for Cancer Survivorship.

During 2000–20, NHS coverage of new drugs displaced more population health than it generated. Our results highlight the inherent trade-offs between individuals who directly benefit from new drugs and those who forgo health due to the reallocation of resources towards new drugs.

Behind MAHA, RFK Jr.’s alternative-health movement, is a legion of Instagram influencers with millions of followers.

Hospitals should remove any barriers to doctors eating and drinking during the working day As healthcare providers, it’s easy to forget to look after ourselves at work. We know that taking breaks and...

When a pediatric psychologist’s young child becomes seriously ill, she learns unsought lessons about better ways of caring for children and their caregivers in devastating circumstances.

The phase 3 SONIA trial challenges the benefits of using cyclin-dependent kinase 4 and 6 inhibitors as a first-line compared with second-line treatment.

These findings might suggest a potential advantage of nab-paclitaxel combined with trastuzumab and pertuzumab compared with the standard regimen in neoadjuvant therapy for patients with HER2-positive ...

The phase 3 SONIA trial challenges the benefits of using cyclin-dependent kinase 4 and 6 inhibitors as a first-line compared with second-line treatment.

In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition...

AbstractBackground. Associations between immune-related adverse events (irAEs) from checkpoint inhibitor therapy and outcomes have been previously evaluate

The annual Global Cardio-Oncology Summit brings together health-care professionals from diverse disciplines including members of the International Cardio-Oncology Society, the only multidisciplinary p...

This systematic review of 17 studies comparing HPA axis function in individuals with cancer as compared to controls suggests that HPA dysregulation is common in people with cancer. There was signific...